NCT05548296 2026-03-24A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaAcrivon TherapeuticsPhase 2 Recruiting353 enrolled
NCT04657068 2026-03-18A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsArtios Pharma LtdPhase 1/2 Recruiting442 enrolled
NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT03314935 2025-08-12A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid TumorsIncyte CorporationPhase 1/2 Completed149 enrolled 35 charts
NCT02393248 2023-01-06Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)Incyte CorporationPhase 1/2 Terminated201 enrolled 71 charts